V. Manna, M.T. Daniele, M. Pinto - Vol. 11, March 2005, Issue 1 - Immagini
Testo Immagini Bibliografia Summary Indice
Oltre i limiti della "personalità limite".
Ruolo dell’impulsività nel disturbo borderline di personalità
Beyond the borders of borderline personalità. Role of impulsiveness
in borderline personalità disorder
1 Manna V, Daniele MT, Pinto M. Fattori ezio-patogenetici del disturbo borderline di personalità. Giornale Italiano di Psicopatologia 2004;10:102-22.
2 Kraepelin E. Psichiatrie: ein Lehrbuch. 2nd Ed. Abel, Leipzig 1887.
3 Bleuler E. Dementia praecox oder Gruppe der Schizophrenien. Verlag von Franz Deulicke, Leipzig 1911.
4 Ey H. Manuel de Psychiatrie. Paris: Masson 1960.
5 Gunderson JG. Borderline personality disorder. Washington DC: American Psychiatric Press 1984.
6 Gunderson JG, Singer MT. Defining borderline patients: an overview. Am J Psychiatry 1975;132:1-10.
7 Bellodi L, Battaglia M, Migone P. Disturbo borderline. In: Pancheri P, Cassano GB, eds. Trattato Italiano di Psichiatria. Milano: Masson 1992, vol. 2, cap. 61, pp. 2002-2010 (II ed: 1999, vol. 2, cap. 61, pp. 2365-2375).
8 American Psychiatric Association. Manuale diagnostico e statistico dei disturbi psichiatrici (DSM III). Milano: Masson 1983.
9 American Psychiatric Association. Manuale diagnostico e statistico dei disturbi mentali (DSM IV). Milano: Masson 1994.
10 American Psychiatric Association. Diagnostic and Statistical manual of mental disorders, 4th Edition. Text revised (DSM IV TR). Washington DC: American Psychiatric Press 2000.
11 Swartz M. Estimating the prevalence of borderline personality disorder in the community. J Personality Disord 1990;4:257-72.
12 Widiger TA, Frances AJ. Epidemiology, diagnosis and comorbidity of borderline personality disorder. In Tasman A, Hales RE, Frances AJ, eds. American Psychiatric Press Review of Psychiatry. American Psychiatric Press 1989, pp. 8-24.
13 Stone MH. The course of borderline personality disorder. In: Tasman A, Hales RE, Frances AJ, eds. American Psychiatric Association, Review of Psychiatry. Washington DC: American Psychiatric Press 1989, pp. 103-122.
14 Akiskal HS. The temperamental borders of affective disorders. Acta Psychiatr Scand 1994;379(Suppl):32-7.
15 Akiskal HS. Subaffective disorders: Dysthymic, cyclothymic and bipolar II disorders in the borderline realm. Psychiatr Clin North Am 1981;4:25-46.
16 Soloff PH, Lynch KG, Kelly TM, Malone KM, Mann JJ. Characteristics of suicide attempts of patients with major depressive episode and borderline personality disorder: a comparative study. Am J Psychiatry 2000;157:601-8.
17 Brodsky BS, Oquendo M, Ellis SP, Haas GL, Malone KM, Mann JJ. The relationship of childhood abuse to impulsivity and suicidaI behavior in adults with major depression. Am J Psychiatry 2001;158:1871-7.
18 Brodsky BS, Malone KM, Ellis SP, Dulit RA, Mann JJ. Characteristics of borderline personality disorder associated with suicidal behavior. Am J Psychiatry 1997;152:1715-9.
19 Herpertz S, Sass H, Favazza A. Impulsivity in self-mutilative behavior: psychometric and biological findings. J Psychiatr Res 1997;31:451-65.
20 Linnoila M, Virkunnen M. Biologic correlates of suicidaI risk and aggressive behavioral acts. J Clin Psychopharmacol 1992;12(Suppl 2):19S-20S.
21 Coccaro EF, Silverman JM, Klar HM. Familial correlates of reduced central serotonergic system function in patients with personality disorders. Arch Gen Psychiatry 1994;51:318-24.
22 Mann JJ, Malone KM, Sweeney JA, Horvath TB, Siever U. Attempted suicide characteristics and cerebrospinal fluid amine metabolites in depressed inpatients. Neuropsychopharmacology 1996;15:576-86.
23 van der Kolk BA, Perry JC, Herman JL.. Childhood origins of self-destructive behavior. Am J Psychiatry 1991;148:1665-71.
24 Boudewyn AC, Liem JH. Psychological, interpersonal, and behavior correlates of chronic self-destructiveness: an exploratory study. Psychol Rep 1995;77:1283-97.
25 Brent DA, Bridge J, Johnson BA, Connolly J. Suicidal behavior runs in families. A controlled family study of adolescent suicide victims. Arch Gen Psychiatry 1996;53:1145-52.
26 Mann JJ, Waternaux C, Haas GL, Malone KM. Toward a clinical model of suicidaI behavior in psychiatric patients. Am J Psychiatry 1999;156:181-9.
27 Levitt Al, Joffe RT, Ennis J, McDonald C, Kutcher SP. The prevalence of cyclothymia in borderline personality disorder. J Clin Psychiatry 1990;51:335-9.
28 Perugi G, Akiskal HS, Lattanzi L. The high prevalence of "soft" bipolar (II) features in atypical depression. Compr Psychiatry 1998;39:63-71.
29 Harmon-Jones E, Barrat ES, Wigg C. Impulsiveness, aggression, reading, and the P300 of the event-related potential. Pers Individ Differences 1997;22:439-5.
30 Swann AC, Janicak PL, Calabrese JR. Structure of mania: depressive, irritable, and psychotic clusters with different retrospectively-assessed course patterns of iIIness in randomized clinical trial participants. J Affect Disord 2001;67:123-32.
31 Rounsaville BJ, Kranzler HR, Ball S. Personality disorders in substance abusers: relation to substance use. J Nerv Ment Dis 1998;186:87-95.
32 Hatzitaskos P, Soldatos CR, Kokkevi A, Stefanis CN. Substance abuse patterns and their association with psychopathology and type of hostility in male patients with borderline and antisocial personality disorder. Compr Psychiatry 1999;40:278-82.
33 Trull TJ, Sher KJ, Minks-Brown C, Durbin J, Burr R. Borderline personality disorder and substance use disorders: a review and integration. Clin Psychol Rev 2000;20:235-53.
34 Verheul R, Kranzler HR, Poling J, Tennen H, Ball S, Rounsaville BJ. Co-occurrence of Axis I and Axis II disorders in substance abusers. Acta Psychiatr Scand 2000;101:110-8.
35 Manna V, Ruggiero S. Dipendenze patologiche da sostanze: comorbilità psichiatrica o continuum psicopatologico? Rivista di Psichiatria 2001;36:1-14.
36 Manna V. Dipendenze patologiche da sostanze e depressione: verso il trattamento integrato multimodale. Minerva Psichiatrica 2002;43:29-35.
37 Manna V, Daniele MT, Pinto M. Psicosi e dipendenze patologiche da sostanze: verso il trattamento integrato multimodale. Giornale Italiano di Psicopatologia 2002;8:36-58.
38 Manna V, Ferrose MC. Alcol-dipendenza, abuso di sostanze e craving: considerazioni cliniche e proposta di un trattamento integrato multimodale. Bollettino Italiano delle Farmacodipendenze e l’Alcolismo 2001;1:50-61.
39 Manna V. Comorbilità psichiatrica delle farmaco-tossicodipendenze. Medicina delle Tossicodipendenze. Organo Ufficiale della Società Italiana Tossicodipendenze 2002;26/27:66-76.
40 Brady KT, Myrick H, McElroy S. The relationship between substance use disorders, impulse control disorders, and pathological aggression. Am J Addict 1998;7:221-30.
41 Moss HB, Yao JK, Panzak JL. Serotonergic responsivity and behavioral dimensions in antisocial personality disorder with substance abuse. Biol Psychiatry 1990;28:325-38.
42 Patton JH, Stanford MS, Barratt ES. Factor structure of the Barratt impulsiveness scale. J Clin Psychol 1995;51:768-74.
43 Allen TJ, Moeller FG, Rhoades HM, Cherek DR. Impulsivity and history of drug dependence. Drug Alcohol Depend 1998;50:137-45.
44 Kruedelbach N, McCormick RA, Schulz SC. Impulsivity, coping styles, and triggers for craving in substance abusers with borderline personality disorder. J Personal Disord 1993;7:214-22.
45 Nagata T, Kawarada Y, Oshima J, Iketani T, Kiriike N. Drug use disorders in Japanese eating disorder patients. Psychiatry Res 2002;109:181-91.
46 Corruble E, Damy C, Guelfi JD. Impulsivity: a relevant dimension in depression regarding suicide attempts? J Affect Disord 1999;53:211-5.
47 Herzog DB, Keller MB, Lavori PW, Kenny GM, Sacks NR. The prevalence of personality disorders in 210 women with eating disorders. J Clin Psychiatry 1992;53:147-52.
48 Rosenvinge JH, Martinussen M, Ostensen E. The comorbidity of eating disorders and personality disorders: a meta-analytic review of studies published between 1983 and 1998. Eat Weight Disord 2000;5:52-61.
49 Matsunaga H, Kaye WH, McConaha C, Plotnicov K, Pollice C, Rao R. Personality disorders among subjects recovered from eating disorders. Int J Eat Disord 2000;27:353-7.
50 Skodol AE, Oldham JM, Hyler SE, Kellman HD, Dodge N, Davies M. Comorbidity of DSM-III-R eating disorders and personality disorders. Int J Eat Disord 1993;14:403-16.
51 Diaz-Marsa M, Carrasco JL, Saiz J. A study of temperament and personality in anorexia and bulimia nervosa. J Personal Disord 2000;14:352-9.
52 Fahy T, Eisler I. Impulsivity and eating disorders. Br J Psychiatry 1993;162:193-7.
53 Paul T, Schroeter K, Dahme B, Nutzinger DO. Self-injurious behavior in women with eating disorders. Am J Psychiatry 2002;159:408-11.
54 Nagata T, Kawarada Y, Kiriike N, Iketani T. Multi-impulsivity of Japanese patients with eating disorders: primary and secondary impulsivity. Psychiatry Res 2000;94:239-50.
55 Sohlberg S, Norring C, Holmgren S, Rosmark B. Impulsivity and long-term prognosis of psychiatric patients with anorexia nervosa/bulimia nervosa. J Nerv Ment Dis 1989;177:249-58.
56 Manna V, Daniele MT, Pinto M. Disedonia. Ruolo della disregolazione omeostatica edonica nelle dipendenze patologiche da sostanze ed in altri disturbi psico-patologici. Giornale Italiano di Psicopatologia 2003;1:71-92.
57 Moeller FG, Barratt ES, Dougherty DM, Swann AC. Psychiatric aspects of impulsivity. Am J Psychiatry 2001;158:1783-93.
58 Looper KJ, Paris J. What dimensions underlie cluster B personality disorders? Compr Psychiatry 2000;41:432-7.
59 Sanislow CA, Grilo CM, Morey CL. Confirmatory factor analysis of DSM-IV criteria for borderline personality disorder: findings from the collaborative longitudinal personality disorders study. Am J Psychiatry 2002;159:284-90.
60 Sanislow CA, Grilo CM, McGlashan TH. Factor analysis of the DSM-III-R border personal criteria in psychiatric inpatients. Am J Psychiatry 2000;157:1629-33.
61 Clarkin JF, Hull JW, Hurt SW. Factor structure of borderline personality disorder criteria. J Personal Disord 1993;7:137-43.
62 Lacey lH, Evans CD. The impulsivist: a multi-impulsive personality disorder. Br J Addict 1986;81:641-9.
63 Westen D, Moses MJ, Silk KR. Quality of depressive experience in borderline personality disorder and major depression: when depression is not just depression. J Personal Disord 1992;6:382-93.
64 Torgersen S. Genetics in borderline conditions. Acta Psychiatr Scand 1994;379(Suppl):19-25.
65 Linehan M. Cognitive-Behavioral Treatment of Borderline Personality Disorder. New York: Guilford 1993.
66 Herpertz S. Self-injurious behaviour. Psychopathological and nosological characteristics in subtypes of self-injurers. Acta Psychiatr Scand 1995;91:57-68.
67 Herpertz S, Gretzer A, Steinmeyer EM, Muehlbauer V, Schuerkens A, Sass H. Affective instability and impulsivity in personality disorder. Results of an experimental study. J Affect Disord 1997;44:31-7.
68 Stone MH. The fate of borderline patients. New York: Guilford 1990.
69 Mehlum L, Friis S, Vaglum P, Karterud S. The longitudinal pattern of suicidal behaviour in borderline personality disorder: A prospective follow-up study. Acta Psychiatr Scand 1994;90:124-30.
70 Zanarini MC. Borderline Personality Disorder as an impulse spectrum disorder. In: Paris L, ed. Borderline personality disorder: etiology and treatment. Washington DC: American Psychiatric Press 1993, pp. 67-85.
71 Links PS, Heslegrave RI, Van Reekum R. Impulsivity: care aspect of borderline personality disorder. J Personal Disord 1999;13:1-9.
72 Coccaro EF, Siever LJ, Klar HM. Serotonergic studies in patients with affective and personality disorders. Correlates with suicidal and impulsive aggressive behavior. Arch Gen Psychiatry 1989;46:587-99.
73 Links PS, Heslegrave Rl. Prospective studies of outcome. Understanding mechanism of change in patients with borderline personality disorder. Psychiatr Clin North Am 2000;23:137-50.
74 Siever U, Buchsbaum MS, New AS. D-L fenfluramine response in impulsive personality disorder assessed with [18F] fluorodeoxyglucose positron emission tomography. Neuropsychopharmacology 1999;20:413-23.
75 Coccaro EF, Bergman CS, McGlearn GE. Heritability of irritable impulsiveness: a study of twins reared together and apart. Psychiatry Res 1993;48:229-42.
76 Coccaro EF. Clinical outcome of psychopharmacologic treatment of borderline and schizotypal personality disordered subjects. J Clin Psychiatry 1998;59(Suppl 1):30-5.
77 Roy A, De Jong J, Linnoila M. Extraversion in pathological gamblers correlates with indexes of noradrenergic function. Arch Gen Psychiatry 1989;46:679-81.
78 Coccaro EF, Lawrence T, Trestman R, Gabriel S, Klar HM, Siever U. Growth hormon responses to intravenous clonidine challenge correlate with behavioral irritability in psychiatric patients and in healthy volunteers. Psychiatry Res 1991;39:129-39.
79 Trestman RL, Coccaro EF, Weston S. Impulsivity, suicidaI behavior. and major depression in the personality disorder: differential correlates with noradrenergic and serotoninergic function. Biol Psychiatry 1992;31:68A.
80 Brown GL, Ebert MH, Goyer PF. Aggression, suicide, and serotonin: relationships to CSF amine metabolites. Am J Psychiatry 1982;139:741-6.
81 Coccaro EF, Gabriel S, Siever U. Buspirone challenge: preliminary evidence for a rate for 5-HT la receptor function in impulsive aggressive behavior in humans. Psychopharmacol Bull 1990;26:393-405.
82 Moss HB, Yao JK, Panzak GL. Serotonergic responsivity and behavioral dimensions in antisocial personality disorder with substance abuse. Biol Psychiatry 1990;28:325-38.
83 Lesch KP, Bengel D, Heils A. Association of anxiety-related traits with a polymorphism in the serotonin transporter gene regulatory region. Science 1996;274:1527-31.
84 New AS, Gelernter J, Goodman M. Suicide, impulsive aggression and HTRIB genotype. Biol Psychiatry 2001;50:62-5.
85 New AS, Gelernter J, Yovell Y. Tryptophan hydroxylase genotype is associated with impulsive-aggression measures: a preliminary study. Am J Med Genet 1998;81:13-7.
86 Manna V, Daniele MT, Pinto M. Farmacoterapia del Disturbo Borderline di Personalità. Ital J Psychopathol 2004;10:376-96.
87 Cowdry RW, Gardner DL. Pharmacotherapy or borderline personality disorder. Alprazolam, carbamazepine, trifluoperazine and tranylcypromine. Arch Gen Psychiatry 1988;45:111-9.
88 Comelius JR, Soloff PH, Perel JM, Ulrich RF. Continuation pharrnacotherapy of borderline personality disorder with haloperidol and phenelzine. Am J Psychiatry 1993;150:1843-8.
89 Soloff PH, Comelius J, George A, Nathan S, Perel JM, Ulrich RF. Efficacy of phenelzine and haloperidol in borderline personality disorder. Arch Gen Psychiatry 1993;50:377-85.
90 Hollander E, Allen A, Lopez RP. A preliminary double-blind, placebo-controlled trial of divalproex sodium in borderline personality disorder. J Clin Psychiatry 2001;62:199-200.
91 Kavoussi RJ, Coccaro EF. Divalproex sodium for impulsive aggressive behavior in patients with personality disorder. J Clin Psychiatry 1998;59:676-80.
92 Stein DJ, Simeon D, Frenkel M, Islam MN, Hollander E. An open trial of valproate in borderline personality disorder. J Clin Psychiatry 1995;56:506-10.
93 Wilcox JA. Divalproex sodium as a treatment for borderline personality disorder. Ann CIin Psychiatry 1995;7:33-7.
94 de La Fuente JM, Lotstra F. A trial of carbamazepine in borderline personality disorder. Eur Neuro-Psycho-Pharmacol 1994;4:479-86.
95 Sheard MH, Marini JL, Bridges CI, Wagner E. The effect of lithium on impulsive aggressive behavior in man. Am J Psychiatry 1976;133:1409-13.
96 Tupin JP, Smith DB, Clanon TL, Kim LI, Nugent A, Groupe A. The long-term use of lithium in aggressive prisoners. Compr Psychiatry 1973;14:311-7.
97 Norden MJ. Fluoxetine in borderline personality disorder. Prog Neuropsycho-pharmacol Biol Psychiatry 1989;13:885-93.
98 American Psychiatric Association. Practice guideline for the treatment of patients with borderline personality disorder. Am J Psychiatry 2001;158(Suppl 10):1-52.
99 Kavoussi RJ, Liu J, Coccaro EF. An open trial of sertraline in personality disordered patients with impulsive aggression. J Clin Psychiatry 1994;55:137-41.
100 Markovitz PJ, Calabrese JR, Schulz SC, Meltzer HY. Fluoxetine in the treatment of borderline and schizotypal personality disorders. Am J Psychiatry 1991;148:1064-7.
101 Comelius JR, Soloff PH, Perel JM, Ulrich RF. Fluoxetine trial in borderline personality disorder. Psychopharmacol Bull 1990;26:151-4.
102 Salzman C, Wolfson AN, Schatzberg A. Effect of fluoxetine on anger in symptomatic volunteers with borderline personality disorder. J Clin Psychopharmacol 1995;15:23-9.
103 Coccaro EF, Kavoussi RJ. Fluoxetine and impulsive aggressive behavior in personality disordered subjects. Arch Gen Psychiatry 1997;54:1081-8.
104 Markovitz P. Pharmacotherapy of impulsivity, aggression, and related disorders. In: Hollander E, Stein DJ, eds. Impulsivity and Aggression. New York: John Wiley and Sons 1995, pp. 263-287.
105 Soloff PH, George A, Nathan S. Amitriptyline versus haloperidol in borderlines: final outcomes and predictors of response. J Clin Psychopharmacol 1989;9:238-46.
106 Soloff PH, George A, Nathan RS, Schulz PM, Ulrich RF, Perel JM. Progress in pharmacotherapy of borderline disorders. A double-blind study of amitriptyline, haloperidol, and placebo. Arch Gen Psychiatry 1986;43:691-7.
107 Serban G, Siegel S. Response of borderline and schizotypal patients to small doses of thiothixene and haloperidol. Am J Psychiatry 1984;141:1455-8.
108 Frankenburg FR, Zanarini MC. Clozapine treatment of borderline patients: a preliminary study. Compr Psychiatry 1993;34:402-5.
109 Chengappa KN, Baker RW, Sirri C. The successful use of clozapine in ameliorating severe self mutilation in a patient with borderline personality disorder. J Personal Disord 1995;9:76-82.
110 Benedetti F, Sforzini L, Colombo C, Maffei C, Smeraldi E. Low-dose clozapine in acute and continuation treatment of severe borderline personality disorder. J Clin Psychiatry 1998;59:100-7.
111 Zanarini MC, Frankenburg FR. Olanzapine treatment of female borderline personality disorder patients: a double-blind, placebo-controlled pilot study. J Clin Psychiatry 2001;62:849-54.
112 Schulz SC, Camlin KL, Berry SA, Jesberger JA. Olanzapine safety and efficacy in patients with borderline personality disorder and comorbid dysthymia. Biol Psychiatry 1999;46:1429-35.
113 Chengappa KN, Ebeling T, Kang JS, Levine J, Parepally H. Clozapine reduces severe self-mutilation and aggression in psychotic patients with borderline personality disorder. J Clin Psychiatry 1999;60:477-84.
114 Szigethy EM, Schulz SC. Risperidone in comorbid borderline personality disorder and dysthymia. J Clin Psychopharmacol 1997;17:326-7.
115 Khouzam HR, Donnelly NJ. Remission of self-mutilation in a patient with borderline personality during risperidone therapy. J Nerv Ment Dis 1997;185:346-7.
116 Hirose S. Effective treatment of aggression and impulsivity in antisocial personality disorder with risperidone. Psychiatry Clin Neurosci 2001;55:161-2.
117 Rocca P, Marchiaro L, Cocuzza E, Bogetto F. Treatment of borderline personality disorder with risperidone. J Clin Psychiatry 2002;63:241-4.
118 Stone MH. Toward a psychobiological theory of borderline personality disorder: is irritability the red threat that runs through borderline conditions? Dissociation 1988;1:2-15.
119 Gunderson JG, Singer MT, Austin V. The Diagnostic Interview for Borderline Patients. Am J Psychiatry 1981;138:896-903.
120 Hilger E, Barnas C, Kasper S. Quetiapine in the treatment of borderline personality disorder. World J Biol Psychiatry 2003;4:42-44.
121 Citrome L, Krakovski M, Greenberg WM, Andrade E, Volavka J. Antiaggressive effect of quetiapine in a patient with schizoaffective disorder. J Clin Psychiatry 2001;62:901.
122 Herpertz S, Sass H, Favazza A. Impulsivity in self-mutilative behaviour: psychometric and biological findings. J Psych Res 1997;31:451-65.
123 Manna V, Daniele MT, Pinto M. Pharmacotherapy of borderline personality disorder: safety and efficacy of the treatment with quetiapine. International Society for the Study of Personality disorders. VIII International ISSPD Congress "Controversial issues in personality disorders" Firenze, 9-12 October 2003, abstract book, p. 150.
124 Manna V.
www.salus.it/medicinadelledipendenze/index.htm. 2001.
125 Bellino S, Rocca P, Marchiaro L, Patria L, Bogetto F. Psicopatologia dell’impulsività e disturbo borderline di personalità. Noos 2003;9:125-45.
126 Links PS, Steiner M, Huxley G. The occurrence of borderline personality disorder in the families of borderline patients. J Personality Disord 1988;2:14-20.
127 Comtois KA, Cowley DS, Dunner DL, Roy-Byrne PP. Relationship between borderline personality disorder and Axis I diagnosis in severity of depression and anxiety. J Clin Psychiatry 1999;60:752-8.
128 Zimmerman M, Mattia N. Axis I diagnostic comorbidity and borderline personality disorder. Compr Psychiatry 1999;40:245-52.
129 Manna V. La comorbilità psichiatrica dell’abuso di sostanze. In: Nizzoli U, Pissacroia G, eds. Trattato completo degli abusi e delle dipendenze. Padova: Piccin 2004, pp. 1313-1330.